Immunocore Holdings Plc

Abingdon, England, United Kingdom immunocore.com

Overview

Immunocore Holdings Plc is a pioneering biotechnology company focused on developing T cell receptor-based therapeutics to treat cancer, infectious diseases, and autoimmune conditions. The company's innovative immune-oncology approach uniquely harnesses and enhances the body's intrinsic immune capabilities to selectively target and combat specific diseases.

Therapeutic areas

OncologyInfectious DiseasesAutoimmune Diseases

FDA compliance signals

1 FDA enforcement record linked to this company.

  • recall — Class II2025-09-10

    Subpotent Drug

Related companies

Biocad
Russia
Celltrion, Inc.
South Korea
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
China
ImmuniTherapeutics Inc.
USA
Immunowake Inc.
United States
Jubilant HollisterStier LLC
United States
ModernaTX, Inc.
USA
NKMAX Bio, Inc.
South Korea

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo